Clonal heterogeneity in membrane expression of CD5 in a patient with chronic lymphocytic leukemia

Ann N Y Acad Sci. 1995 Sep 29:764:482-4. doi: 10.1111/j.1749-6632.1995.tb55869.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, Neoplasm / biosynthesis*
  • Antigens, Neoplasm / genetics
  • Antigens, Neoplasm / metabolism
  • Antigens, Surface / biosynthesis*
  • Antigens, Surface / genetics
  • Antigens, Surface / metabolism
  • B-Lymphocyte Subsets / drug effects
  • B-Lymphocyte Subsets / metabolism*
  • Base Sequence
  • CD5 Antigens / biosynthesis*
  • CD5 Antigens / genetics
  • CD5 Antigens / metabolism
  • Clone Cells / metabolism*
  • Cohort Studies
  • Gene Expression Regulation, Leukemic*
  • Gene Rearrangement, B-Lymphocyte, Heavy Chain
  • Genes, Immunoglobulin
  • Humans
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin G / genetics
  • Immunoglobulin Heavy Chains / genetics
  • Immunoglobulin Variable Region / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • RNA, Messenger / biosynthesis
  • RNA, Neoplasm / biosynthesis
  • Sequence Alignment
  • Sequence Homology, Nucleic Acid
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Antigens, Neoplasm
  • Antigens, Surface
  • CD5 Antigens
  • Immunoglobulin G
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Variable Region
  • RNA, Messenger
  • RNA, Neoplasm
  • Tetradecanoylphorbol Acetate